Share This Page

 
Now on Twitter!

Follow us: ChinaBio

Site Search

>> Advanced Search

  Quick Search:
 
 

Free Newsletter

  Email address:
   

Free White Paper

AsiaPharm Accepts Private Equity Offer

publication date: Feb 6, 2008
View a Printer Friendly version of this page, allowing you to print the page. Send a summary of this page to someone via email.

AsiaPharm Group received an offer from private equity firm MBK Partners to take the company private for $253 million. MBK has been assured that stockholders holding 44% of the outstanding shares will vote in favor of the proposal. AsiaPharm is listed on the Singapore exchange, but its operations are in China. MBK, which manages $1.5 billion, is based in the Cayman Islands and focuses on Asia. We look at the deal.  More details...

Stock Symbol: (SI: ASPH)




Sorry... this feature or article is only available to subscribers.

>> Learn more about our subscription plans...

>> Free email newsletter...

>> Login...


Login

  

    
   
ChinaBio® Events

ChinaBio® Partnering Forum 2012
May 23-24, 2012
Suzhou, China

>>More events...
Partner Events

China Healthcare Investment Conference 2012
March 13-15, 2012
Shanghai, China


Shanghai CEO Conference
March 28-29, 2012
Shanghai, China

>>More details...
Our Partners
Annual Sponsors
 
Official Partners
 
Supporting Partners
 
Media Partners